¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPSC) »ý»ê ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ÇÁ·Î¼¼½ºº°, Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Induced Pluripotent Stem Cells Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Process, By Product, By Application, By End-user, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1732822
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPSC) »ý»ê ½ÃÀåÀº 2024³â 13¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 24¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 10.44%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

iPSC´Â ÀÚ°¡ Àç»ý ¹× ¿©·¯ ¼¼Æ÷ À¯ÇüÀ¸·Î ºÐÈ­ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ÀÎÇØ Àç»ý ÀÇÇÐ ºÐ¾ß¿¡¼­ ȹ±âÀûÀÎ Çõ½ÅÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÇǺγª Ç÷¾×¿¡¼­ ÃßÃâÇÑ ¼¼Æ÷¿Í °°Àº ¼ºÃ¼ ¼¼Æ÷¸¦ ÀçÇÁ·Î±×·¡¹ÖÇÏ¿© ÃßÃâÇÑ iPSC´Â ¹è¾Æ Áٱ⼼Æ÷¿Í À¯»çÇÑ Æ¯¼ºÀ» º¸ÀÌ´Â µ¿½Ã¿¡ ±âÁ¸ ¿øÃµ°ú °ü·ÃµÈ À±¸®Àû, ¸é¿ªÇÐÀû ¹®Á¦¸¦ ÇØ°áÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¿ëµµ¼º ´öºÐ¿¡ Àç»ý Ä¡·á, ¾à¹° ½ºÅ©¸®´×, Áúº´ ¸ðµ¨¸µ¿¡ Áß¿äÇÑ µµ±¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ½Å°æÇÐ, ½ÉÀåÇÐ, ´ë»ç Àå¾Ö Àü¹Ý¿¡ °ÉÄ£ ÀÀ¿ë ºÐ¾ßÀÇ Áõ°¡¿¡ ÈûÀÔ¾î iPSC ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ½ÃÀåÀº ºü¸£°Ô È®ÀåµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇÇÐÀ¸·ÎÀÇ Àüȯ°ú ¼ºÀÎ À¯·¡ ¼¼Æ÷ »ç¿ëÀÇ À±¸®Àû ÀÌÁ¡Àº ¼ö¿ä¸¦ ´õ¿í °­È­ÇÏ¿© Â÷¼¼´ë »ýÀÇÇÐ ¿¬±¸ ¹× Ä¡·áÁ¦ °³¹ßÀÇ Ãʼ®À¸·Î iPSC¸¦ ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð(2024³â) 13¾ï 5,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð(2030³â) 24¾ï 5,000¸¸ ´Þ·¯
CAGR(2025-2030³â) 10.44%
±Þ¼ºÀå ºÎ¹® ½Å¾à °³¹ß ¹× ¹ß°ß
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

Ä¡·á ¿ëµµ È®´ë

ÁÖ¿ä ½ÃÀå °úÁ¦

»ý»ê ºñ¿ë

ÁÖ¿ä ½ÃÀå µ¿Çâ

Áúº´ ¸ðµ¨¸µ ¹× ½Å¾à °³¹ß¿¡¼­ÀÇ ¿ëµµ Áõ°¡

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ Àΰø ´Ù´É¼º Áٱ⠼¼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø ´Ù´É¼º Áٱ⠼¼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷ »ý»ê ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ ¹× ¹ßÀü

Á¦13Àå PESTEL ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Induced Pluripotent Stem Cells (iPSCs) Production Market was valued at USD 1.35 billion in 2024 and is projected to reach USD 2.45 billion by 2030, growing at a CAGR of 10.44% during the forecast period. iPSCs have emerged as a transformative innovation in regenerative medicine due to their ability to self-renew and differentiate into multiple cell types. Derived by reprogramming adult cells like those from skin or blood, iPSCs exhibit properties similar to embryonic stem cells while addressing ethical and immunological concerns associated with traditional sources. Their versatility positions them as vital tools for regenerative therapies, drug screening, and disease modeling. With advancements in iPSC technology, the market is expanding rapidly, driven by growing applications across neurology, cardiology, and metabolic disorders. The shift towards personalized medicine and the ethical benefits of using adult-derived cells further bolster demand, establishing iPSCs as a cornerstone in next-generation biomedical research and therapeutic development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.35 Billion
Market Size 2030USD 2.45 Billion
CAGR 2025-203010.44%
Fastest Growing SegmentDrug Development and Discovery
Largest MarketNorth America

Key Market Drivers

Expanding Therapeutic Applications

The potential of iPSCs in clinical therapy is continuously growing as they are applied to an expanding spectrum of diseases. Their ability to differentiate into various specialized cell types makes them highly promising for treating complex conditions such as Parkinson's disease, Alzheimer's, cardiovascular disorders, and diabetes. iPSCs derived from adult cells can be engineered into dopaminergic neurons, offering targeted treatment pathways and facilitating drug development for neurodegenerative conditions. Similarly, their application in cardiac regeneration is gaining traction, with researchers using iPSC-derived cardiac cells to model heart diseases and explore regenerative options post-injury. The increasing adoption of iPSCs in these therapeutic areas not only enhances treatment potential but also broadens the market for their production, as healthcare systems and patients alike seek advanced, tailored solutions.

Key Market Challenges

Cost of Production

A major limitation hindering the widespread adoption of iPSC technologies is the high cost associated with their generation and maintenance. The reprogramming of adult cells into iPSCs involves resource-intensive processes that require high-end laboratory infrastructure, advanced equipment, and skilled personnel. Furthermore, the culture media and reagents used in iPSC production are costly and must comply with strict quality standards to ensure consistency and safety. These operational expenses create significant financial barriers for both academic and commercial entities attempting to scale production for therapeutic use. Consequently, the cost of iPSC-based therapies remains high, limiting accessibility for broader patient groups and posing challenges for market scalability.

Key Market Trends

Growing Applications in Disease Modeling and Drug Development

The increasing use of iPSCs in disease modeling and pharmaceutical research is a key trend driving market growth. iPSCs can be generated from individuals with specific genetic profiles, enabling the creation of personalized disease models. These models provide valuable platforms for understanding disease mechanisms and testing drug responses in conditions such as genetic disorders, neurodegenerative diseases, and cardiovascular anomalies. Pharmaceutical companies are leveraging iPSC technology to enhance drug discovery pipelines, enabling more accurate candidate screening and reducing development timelines and costs. The rising emphasis on precision medicine further amplifies the need for iPSC-derived models, reinforcing their significance in both academic research and commercial drug development.

Key Market Players

Report Scope:

In this report, the Global Induced Pluripotent Stem Cells Production Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Induced Pluripotent Stem Cells Production Market, By Process:

Induced Pluripotent Stem Cells Production Market, By Product:

Induced Pluripotent Stem Cells Production Market, By End-user:

Induced Pluripotent Stem Cells Production Market, By Application:

Induced Pluripotent Stem Cells Production Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Induced Pluripotent Stem Cells Production Market.

Available Customizations:

Global Induced Pluripotent Stem Cells Production market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Induced Pluripotent Stem Cells Production Market Outlook

6. North America Induced Pluripotent Stem Cells Production Market Outlook

7. Europe Induced Pluripotent Stem Cells Production Market Outlook

8. Asia-Pacific Induced Pluripotent Stem Cells Production Market Outlook

9. South America Induced Pluripotent Stem Cells Production Market Outlook

10. Middle East and Africa Induced Pluripotent Stem Cells Production Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â